Matthew Labenski

Company: Jnana Therapeutics

Job title: Senior Director - Proteomics & Chemical Biology

Seminars:

RAPID – Photoaffinity-Based High-Throughput Ligand Discovery in Cells 3:00 pm

Pivoting away from mass spec in favor of building a high-throughput chemotherapeutics hit identification platform Discovery of first-in-class inhibitors of a genetically validated target for the treatment of PKU Discovery of the first inhibitors for transcription factor IRF3 Evolving the platform to work with other covalent warheadsRead more

day: Day One